David Krempa | Senior Vice President of Business Development & Investor Relations |
Sean Brynjelsen | President & Chief Executive Officer |
James Gruber | Chief Financial Officer |
Raghuram Selvaraju | H.C. Wainwright & Co. |
Good afternoon and welcome to the Eton Pharmaceuticals Second Quarter '22 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company's request. At this time, I would like to turn it over to David Krempa, Senior Vice President of Business Development and Investor Relations at Eton Pharmaceuticals. Please proceed.
Thank you, operator.